Insiders · PRDS

Mark Auerbach

Director at Pardes Biosciences, Inc. (PRDS)

Mark Auerbach has filed 5 insider reports with the SEC since December 2021, as director at Pardes Biosciences, Inc. (PRDS) and director at Pardes Biosciences, Inc. (FSII). The latest filing, on August 31, 2023, reports sale back to the company and tender of shares in a change of control at Pardes Biosciences, Inc. (PRDS).

Filings
5
Companies
2
Bought on market
None
Sold on market
None

Companies where Mark Auerbach is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Pardes Biosciences, Inc. logo
PRDS
Pardes Biosciences, Inc.
Director0Aug 31, 2023
Pardes Biosciences, Inc. logo
FSII
Pardes Biosciences, Inc.
Directorsince December 202170,390Dec 28, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Mark Auerbach.

Compare Mark Auerbach with

Questions about Mark Auerbach

What is Mark Auerbach's role at Pardes Biosciences, Inc.?
Mark Auerbach reports to the SEC as director at Pardes Biosciences, Inc. (PRDS), according to the latest filing on August 31, 2023. Mark Auerbach has also filed as director at Pardes Biosciences, Inc. (FSII).
How many shares does Mark Auerbach own?
After the latest filing that states it, Mark Auerbach directly owned 70,390 shares of Pardes Biosciences, Inc. (FSII). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Mark Auerbach bought or sold stock recently?
No open-market purchases or sales by Mark Auerbach are on file. The filings report sale back to the company, tender of shares in a change of control and grant or award.
How do I get alerts when Mark Auerbach files?
Follow Mark Auerbach on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Mark Auerbach (SEC CIK 0001018007). Totals count each trade once, skipping amendments whose original is on file, from Dec 27, 2021 on. View on SEC EDGAR